ATH 0.00% 0.3¢ alterity therapeutics limited

end of the downside- back in, page-91

  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    Dje, what kind of news you are expecting about PBT2?

    IMO the possibilities are:

    1. Cardiac Light Chain Amyloidosis ( Diomede et al, 2017 ) related activity (phase 2, perhaps orphan disease application)
    2. Co-operation with Queensland university about treating antibiotic-resistant infections ( human and food industry )
    3. Possible deal with the new big pharma co-operation to target development of new antibiotics
    4. Covid-19 related news, PBT2 possibilities to kill viruses
    5. patent-related news, related to the above issues
    6. else
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.